NOREPINEPHRINE BITARTRATE

N/A

Manufactured by Deseret Biologicals, Inc.

35,563 FDA adverse event reports analyzed

Last updated: 2026-04-14

About NOREPINEPHRINE BITARTRATE

NOREPINEPHRINE BITARTRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Deseret Biologicals, Inc.. The most commonly reported adverse reactions for NOREPINEPHRINE BITARTRATE include DRUG INEFFECTIVE, HYPOTENSION, OFF LABEL USE, ACUTE KIDNEY INJURY, MULTIPLE ORGAN DYSFUNCTION SYNDROME. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for NOREPINEPHRINE BITARTRATE.

Top Adverse Reactions

DRUG INEFFECTIVE2,740 reports
HYPOTENSION1,392 reports
OFF LABEL USE1,270 reports
ACUTE KIDNEY INJURY890 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME804 reports
SEPSIS790 reports
CONDITION AGGRAVATED777 reports
RENAL FAILURE728 reports
TOXICITY TO VARIOUS AGENTS708 reports
CARDIAC ARREST698 reports
CARDIOGENIC SHOCK664 reports
SEPTIC SHOCK631 reports
DEATH599 reports
RESPIRATORY FAILURE583 reports
PAIN482 reports
PNEUMONIA474 reports
STRESS473 reports
SHOCK457 reports
VOMITING440 reports
METABOLIC ACIDOSIS425 reports
NAUSEA402 reports
PRODUCT USE IN UNAPPROVED INDICATION394 reports
RENAL IMPAIRMENT392 reports
DRUG INTERACTION389 reports
TACHYCARDIA387 reports
BRADYCARDIA386 reports
GENERAL PHYSICAL HEALTH DETERIORATION381 reports
ABDOMINAL PAIN375 reports
ANXIETY370 reports
INJURY370 reports
DYSPNOEA359 reports
INTENTIONAL OVERDOSE359 reports
ANAEMIA358 reports
OVERDOSE356 reports
HYPONATRAEMIA353 reports
PYREXIA346 reports
LACTIC ACIDOSIS345 reports
UNEVALUABLE EVENT339 reports
THROMBOCYTOPENIA333 reports
MULTI ORGAN FAILURE321 reports
VENTRICULAR FIBRILLATION313 reports
ASCITES311 reports
FEAR307 reports
ABDOMINAL DISTENSION306 reports
ACUTE RESPIRATORY DISTRESS SYNDROME289 reports
CONSTIPATION281 reports
EMOTIONAL DISTRESS280 reports
RENAL INJURY278 reports
SOMNOLENCE269 reports
APPENDICITIS265 reports
APPENDICOLITH260 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION257 reports
COMA251 reports
PULMONARY EMBOLISM247 reports
HYPOXIA246 reports
RHABDOMYOLYSIS246 reports
HYPERTENSION245 reports
ATRIAL FIBRILLATION227 reports
BLOOD CREATININE INCREASED227 reports
ANHEDONIA223 reports
HAEMODYNAMIC INSTABILITY220 reports
BLOOD PRESSURE DECREASED219 reports
ELECTROCARDIOGRAM QT PROLONGED215 reports
PLEURAL EFFUSION211 reports
ALANINE AMINOTRANSFERASE INCREASED207 reports
VENTRICULAR TACHYCARDIA206 reports
TOXIC EPIDERMAL NECROLYSIS200 reports
DRUG HYPERSENSITIVITY199 reports
PULMONARY OEDEMA196 reports
RENAL FAILURE ACUTE196 reports
INTENTIONAL PRODUCT MISUSE187 reports
THROMBOSIS187 reports
HYPERKALAEMIA185 reports
FOETAL EXPOSURE DURING PREGNANCY182 reports
CARDIO RESPIRATORY ARREST175 reports
ASPARTATE AMINOTRANSFERASE INCREASED174 reports
BLOOD PHOSPHORUS INCREASED174 reports
SEROTONIN SYNDROME174 reports
DIARRHOEA172 reports
ASTHENIA170 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS170 reports
DIABETES MELLITUS169 reports
DRY MOUTH167 reports
BACTERIAL INFECTION162 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE160 reports
PLATELET COUNT DECREASED156 reports
TROPONIN INCREASED155 reports
CARDIAC FAILURE153 reports
MATERNAL EXPOSURE DURING PREGNANCY153 reports
MYASTHENIA GRAVIS152 reports
SWELLING152 reports
THERAPY NON RESPONDER148 reports
DISSEMINATED INTRAVASCULAR COAGULATION146 reports
INCORRECT ROUTE OF PRODUCT ADMINISTRATION146 reports
DRUG INTOLERANCE145 reports
BLOOD CHOLESTEROL INCREASED144 reports
HAEMORRHAGE144 reports
SEIZURE144 reports
CIRCULATORY COLLAPSE141 reports
ACUTE RESPIRATORY FAILURE139 reports

Report Outcomes

Out of 13,620 classified reports for NOREPINEPHRINE BITARTRATE:

Serious 96.2%Non-Serious 3.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male6,914 (55.6%)
Female5,494 (44.2%)
Unknown26 (0.2%)

Reports by Age

Age 80400 reports
Age 68311 reports
Age 67304 reports
Age 60262 reports
Age 62253 reports
Age 64250 reports
Age 65249 reports
Age 61239 reports
Age 59238 reports
Age 74237 reports
Age 75236 reports
Age 66235 reports
Age 49232 reports
Age 71224 reports
Age 53221 reports
Age 69220 reports
Age 55219 reports
Age 63211 reports
Age 57204 reports
Age 70204 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with NOREPINEPHRINE BITARTRATE?

This profile reflects 35,563 FDA FAERS reports that mention NOREPINEPHRINE BITARTRATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for NOREPINEPHRINE BITARTRATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, HYPOTENSION, OFF LABEL USE, ACUTE KIDNEY INJURY, MULTIPLE ORGAN DYSFUNCTION SYNDROME, SEPSIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures NOREPINEPHRINE BITARTRATE?

Labeling and FAERS entries often list Deseret Biologicals, Inc. in connection with NOREPINEPHRINE BITARTRATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.